VAN KALSBEEK, R. J ., H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN, R. EFFENEY, J. F. WINTHER, C. FOLLIN, J. DEN HARTOGH, R. HAUPT, L. HJORTH, Tomáš KEPÁK, Kateřina KEPÁKOVÁ, G. LEVITT, J. J. LOONEN, M. MANGELSCHOTS, M. MURACA, M. RENARD, H. SABIC, C. U. SCHNEIDER, A. UYTTEBROECK, R. SKINNER and R. L. MULDER. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. European Journal of Cancer. Oxford: Elsevier Science Inc., 2021, vol. 154, September 2021, p. 316-328. ISSN 0959-8049. Available from: https://dx.doi.org/10.1016/j.ejca.2021.06.004.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
Authors VAN KALSBEEK, R. J . (guarantor), H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN, R. EFFENEY, J. F. WINTHER, C. FOLLIN, J. DEN HARTOGH, R. HAUPT, L. HJORTH, Tomáš KEPÁK (203 Czech Republic, belonging to the institution), Kateřina KEPÁKOVÁ (203 Czech Republic, belonging to the institution), G. LEVITT, J. J. LOONEN, M. MANGELSCHOTS, M. MURACA, M. RENARD, H. SABIC, C. U. SCHNEIDER, A. UYTTEBROECK, R. SKINNER and R. L. MULDER.
Edition European Journal of Cancer, Oxford, Elsevier Science Inc. 2021, 0959-8049.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.002
RIV identification code RIV/00216224:14110/21:00124150
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ejca.2021.06.004
UT WoS 000686049700036
Keywords in English Neoplasms; Cancer survivors; Survivorship; Aftercare; Practice guideline; Patient participation; Quality of life
Tags 14110321, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/2/2022 08:31.
Abstract
Background: Long-term follow-up (LTFU) care for childhood, adolescent, and young adult (CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence-based guidelines are needed to inform optimal surveillance strategies, but many topics are yet to be addressed by the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG). Therefore, the PanCareFollowUp Recommendations Working Group collaborated with stakeholders to develop European harmonised recommendations in anticipation of evidence-based IGHG guidelines. Methods: The PanCareFollowUp Recommendations Working Group, consisting of 23 late effects specialists, researchers, and survivor representatives from nine countries, collaborated in the first Europe-wide effort to provide unified recommendations in anticipation of evidence based guidelines. A pragmatic methodology was used to define recommendations for topics where no evidence-based IGHG recommendations exist. The objective was to describe the surveillance requirements for high-quality care while balancing the different infrastructures and resources across European health care systems. The process included two face-to-face meetings and an external consultation round involving 18 experts from 14 countries. Results: Twenty-five harmonised recommendations for LTFU care were developed collaboratively and address topics requiring awareness only (n = 6), awareness, history and/or physical examination (n = 9), or additional surveillance tests (n = 10). Conclusions: The PanCareFollowUp Recommendations, representing a unique agreement across European stakeholders, emphasise awareness among survivors and health care providers in addition to tailored clinical evaluation and/or surveillance tests. They include existing IGHG guidelines and additional recommendations developed by a pragmatic methodology and will be used in the Horizon 2020-funded PanCareFollowUp project to improve health and QoL of CAYA cancer survivors. (C) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PrintDisplayed: 2/9/2024 06:21